National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

allogeneic multipotent adult progenitor cells
A biologic product that consists of undifferentiated stem cells, obtained from adult bone marrow or other non-embryonic tissue sources, that are expanded in vitro and deposited in master cell banks for "off-the-shelf" use, with potential hematopoiesis-inducing and immunomodulating activities. Allogeneic multipotent adult progenitor cells (MAPCs) are non-immunogenic due to the lack of major histocompatibility (MHC) molecule expression, and so elicit no immune response upon administration. In vivo, bone marrow-derived adult stem cells are capable of maturing into a broad range of cell types and may help restore the immune system by producing multiple therapeutic molecules in response to inflammation and tissue damage. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:MultiStem



Previous:allogeneic dendritic cell-myeloma idiotype vaccine, allogeneic GM-CSF-secreting breast cancer vaccine, allogeneic large multivalent immunogen melanoma vaccine LP2307, allogeneic LMP1-/LMP2- specific cytotoxic T-lymphocytes, allogeneic melanoma vaccine AGI-101H
Next:allogeneic tumor cell vaccine, allopurinol, aloe vera gel, Aloxi, alpha fetoprotein adenoviral vector vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov